CME Group(DE:MX4A)
€286.10+4.40 (+1.56%)
DE:MX4A
CME Group stock forecast
€286.10
At close:+4.40 (+1.56%)
CME Group (MX4A) Stock Forecast & Price Target
3 Followers
MX4A Analyst Ratings
Moderate Buy
6Buy4Hold2Sell
Based on 12 analysts giving stock ratings to CME Group in the past 3 months
MX4A Stock 12 Month Forecast
Average Price Target
€279.37▼(-2.35% Downside)Based on 12 Wall Street analysts offering 12 month price targets for CME Group in the last 3 months. The average price target is EUR 279.37 with a high forecast of EUR 330.73 and a low forecast of EUR 204.57. The average price target represents a -2.35% change from the last price of EUR 286.10.
Past 12 Months12 Month ForecastJan2026Oct2026
High€330.73
Average€279.37
Low€204.57
Highest Price TargetHighest€330.73Average Price Target€279.37Lowest Price TargetLowest€204.57
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Alexander Blostein | Goldman Sachs | €228.90→€244.22 | sell | -14.64%Downside | Reiterated | 10/23/26 | ||
| Benjamin Budish | Barclays | €243.32→€289.28 | hold | 1.11%Upside | Reiterated | 10/22/26 | ||
| Daniel Welden | Wells Fargo | €283.87→€300.09 | buy | 4.89%Upside | Assigned | 10/22/26 | ||
| Christopher Allen | KBW | €292.88→€297.39 | buy | 3.95%Upside | Reiterated | 10/22/26 | ||
| Michael Cyprys | Morgan Stanley | €303.70→€323.52 | buy | 13.08%Upside | Reiterated | 10/22/26 | ||
| Ken Worthington | J.P. Morgan | €225.29→€330.73 | buy | 15.60%Upside | Upgraded | 10/22/26 | ||
| Alex Kramm | UBS | €243.32→€279.37 | hold | -2.35%Downside | Reiterated | 10/22/26 | ||
| Patrick Moley | Piper Sandler | €265.85→€297.39 | buy | 3.95%Upside | Reiterated | 10/22/26 | ||
| Craig Siegenthaler | Bank of America Securities | €196.46→€204.57 | sell | -28.50%Downside | Reiterated | 10/21/26 | ||
| Ashish Sabadra | RBC Capital | €272.16 | hold | -4.87%Downside | Reiterated | 10/20/26 | ||
| William Katz | TD Cowen | €263.14→€270.35 | buy | -5.50%Downside | Reiterated | 10/05/26 | ||
| Brian Bedell | Deutsche Bank | €243.32 | hold | -14.95%Downside | Downgraded | 08/19/26 | ||
| Hans Engel | Erste Group | ― | hold | ― | Reiterated | 06/24/26 | ||
| Simon Clinch | Rothschild & Co Redburn | €291.08 | buy | 1.74%Upside | Upgraded | 06/11/26 | ||
| Kevin Heal | Argus Research | ― | hold | ― | Downgraded | 03/03/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Alexander BlosteinGoldman Sachs | SellReiterated€228.90→€244.22 | 10/23/26 | -14.64%Downside | ||
| Benjamin BudishBarclays | HoldReiterated€243.32→€289.28 | 10/22/26 | 1.11%Upside | ||
| Daniel WeldenWells Fargo | BuyAssigned€283.87→€300.09 | 10/22/26 | 4.89%Upside | ||
| Christopher AllenKBW | BuyReiterated€292.88→€297.39 | 10/22/26 | 3.95%Upside | ||
| Michael CyprysMorgan Stanley | BuyReiterated€303.70→€323.52 | 10/22/26 | 13.08%Upside | ||
| Ken WorthingtonJ.P. Morgan | BuyUpgraded€225.29→€330.73 | 10/22/26 | 15.60%Upside | ||
| Alex KrammUBS | HoldReiterated€243.32→€279.37 | 10/22/26 | -2.35%Downside | ||
| Patrick MoleyPiper Sandler | BuyReiterated€265.85→€297.39 | 10/22/26 | 3.95%Upside | ||
| Craig SiegenthalerBank of America Securities | SellReiterated€196.46→€204.57 | 10/21/26 | -28.50%Downside | ||
| Ashish SabadraRBC Capital | HoldReiterated€272.16 | 10/20/26 | -4.87%Downside | ||
| William KatzTD Cowen | BuyReiterated€263.14→€270.35 | 10/05/26 | -5.50%Downside | ||
| Brian BedellDeutsche Bank | HoldDowngraded€243.32 | 08/19/26 | -14.95%Downside | ||
| Hans EngelErste Group | HoldReiterated | 06/24/26 | ― | ||
| Simon ClinchRothschild & Co Redburn | BuyUpgraded€291.08 | 06/11/26 | 1.74%Upside | ||
| Kevin HealArgus Research | HoldDowngraded | 03/03/26 | ― |
Stocks with the Highest Top Analyst Consensus in the Financial Sector
Best Analysts Covering CME Group
3 Months
Success Rate13/15 ratings generated profit
87%
Average Return
+8.21%
Copying Christopher Allen's trades and holding each position for 3 Months would result in 86.67% of your transactions generating a profit, with an average return of +8.21% per trade.
1 Year
Success Rate15/15 ratings generated profit
100%
Average Return
+15.15%
Copying Christopher Allen's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +15.15% per trade.
2 Years
Success Rate19/19 ratings generated profit
100%
Average Return
+30.47%
Copying Patrick Moley's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +30.47% per trade.
MX4A Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 10 | 10 | 9 | 13 | 13 |
| Hold | 14 | 15 | 10 | 8 | 6 |
| Sell | 6 | 6 | 4 | 4 | 4 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 30 | 31 | 23 | 25 | 23 |
In the current month, MX4A has received 13 Buy Ratings, 6 Hold Ratings, and 4 Sell Ratings. MX4A average Analyst price target in the past 3 months is 279.37.
MX4A Financial Forecast
High€2.96
Consensus€2.74
Low€2.64
MX4A Earnings Forecast
Next quarter’s earnings estimate for MX4A is EUR 2.74 with a range of EUR 2.64 to EUR 2.96. The previous quarter’s EPS was EUR 2.73. Its overall industry beat the EPS estimate 81.82% of the time in the past 12 months.
High€1.63B
Consensus€1.59B
Low€1.56B
MX4A Sales Forecast
Next quarter’s sales forecast for MX4A is EUR 1.59B with a range of EUR 1.56B to EUR 1.63B. The previous quarter’s sales results were EUR 1.57B. Its overall industry beat sales estimates 93.33% of the time in the past 12 months.
MX4A Stock Forecast FAQ
What is DE:MX4A’s average 12-month price target, according to analysts?
Based on analyst ratings, CME Group’s 12-month average price target is €279.37.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CME Group a Buy, Sell or Hold?
CME Group has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 4 hold ratings and 2 sell ratings.
What is CME Group’s share price target?
The average share price target for CME Group is €279.37. This is based on 12 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €330.73, and the lowest forecast is €204.57. The average share price target represents a 2.35% decrease from the current price of €286.1.
What do analysts say about CME Group?
CME Group’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Street analysts.
How can I buy shares of CME Group?
To buy shares of DE:MX4A, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
